car-t therapies at the point-of-care, a galapagos company
Biotechnology Research
Oegstgeest, south holland
Founded in 2018
11-50 employees
cellpoint enables clinicians to treat hematological malignancies by retargeting patient immune cells at the point-of-care. get in touch or visit our website: https://cellpoint.bio
Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.